IMC-11F8

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IMC-11F8, covering 2010-10-13 to 2017-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of IMC-11F8 in Participants With Advanced Solid Tumors [Phase 1]